FR5581M - - Google Patents

Info

Publication number
FR5581M
FR5581M FR41483A FR41483A FR5581M FR 5581 M FR5581 M FR 5581M FR 41483 A FR41483 A FR 41483A FR 41483 A FR41483 A FR 41483A FR 5581 M FR5581 M FR 5581M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR41483A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR19960A priority Critical patent/FR1461407A/fr
Priority claimed from FR19960A external-priority patent/FR1461407A/fr
Priority to FR35359A priority patent/FR94302E/fr
Application filed filed Critical
Priority to FR41483A priority patent/FR5581M/fr
Application granted granted Critical
Publication of FR5581M publication Critical patent/FR5581M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR41483A 1965-06-09 1965-12-09 Expired FR5581M (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR19960A FR1461407A (fr) 1965-06-09 1965-06-09 Nouveaux pamoates d'amines et procédés de leur préparation
FR35359A FR94302E (fr) 1965-06-09 1965-10-19 Nouveaux pamoates d'amines et procédés de leur préparation.
FR41483A FR5581M (de) 1965-06-09 1965-12-09

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR19960A FR1461407A (fr) 1965-06-09 1965-06-09 Nouveaux pamoates d'amines et procédés de leur préparation
FR41483A FR5581M (de) 1965-06-09 1965-12-09

Publications (1)

Publication Number Publication Date
FR5581M true FR5581M (de) 1967-12-04

Family

ID=26164070

Family Applications (1)

Application Number Title Priority Date Filing Date
FR41483A Expired FR5581M (de) 1965-06-09 1965-12-09

Country Status (1)

Country Link
FR (1) FR5581M (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097523A3 (en) * 1982-06-21 1984-12-12 Euroceltique Sa Extended action controlled release compositions
EP0137600A1 (de) * 1983-07-20 1985-04-17 Euroceltique S.A. Pharmazeutisch aktive Salze von Morphin
GB2172283A (en) * 1985-03-15 1986-09-17 Yliopiston Apteekki Naxaping salt
US9226925B1 (en) * 2006-11-10 2016-01-05 Pisgah Laboratories, Inc. Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097523A3 (en) * 1982-06-21 1984-12-12 Euroceltique Sa Extended action controlled release compositions
EP0137600A1 (de) * 1983-07-20 1985-04-17 Euroceltique S.A. Pharmazeutisch aktive Salze von Morphin
GB2172283A (en) * 1985-03-15 1986-09-17 Yliopiston Apteekki Naxaping salt
US9226925B1 (en) * 2006-11-10 2016-01-05 Pisgah Laboratories, Inc. Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder

Similar Documents

Publication Publication Date Title
BE674759A (de)
BE674606A (de)
BE660483A (de)
BE661907A (de)
BE665425A (de)
BE665788A (de)
BE665895A (de)
BE666060A (de)
BE666341A (de)
BE666658A (de)
BE667281A (de)
BE668330A (de)
BE668724A (de)
BE668816A (de)
BE669446A (de)
BE669659A (de)
BE671675A (de)
BE671701A (de)
BE672013A (de)
BE672252A (de)
BE672661A (de)
BE672703A (de)
BE672745A (de)
BE672778A (de)
BE672829A (de)